TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 0.300nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 0.340nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 0.350nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 0.400nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 0.480nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 0.490nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 0.540nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 0.550nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 0.570nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 0.590nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 0.610nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 0.660nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 0.680nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 0.790nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 0.880nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 0.970nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 0.990nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 1.10nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 1.30nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 1.60nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 1.90nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 2.20nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 3nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 4.60nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 4.67nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 12nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 4 [75-147](Homo sapiens (Human))
Jacobio Pharmaceuticals
US Patent
Jacobio Pharmaceuticals
US Patent
Affinity DataIC50: 17nMAssay Description:Briefly, 20 nL of compounds were transferred to the 384-well plate by EchoŽ 550 liquid handler (Labcyte, USA), then 5 μL of BRD4(BD1) (Reaction ...More data for this Ligand-Target Pair